Thyronamine: Difference between revisions
Appearance
Content deleted Content added
Tom.Reding (talk | contribs) m →Types: CS1 maintenance: vauthors/veditors or enumerate multiple authors/editors; WP:GenFixes on, using AWB |
removed Category:Phenols; added Category:4-Hydroxyphenyl compounds using HotCat |
||
(5 intermediate revisions by 5 users not shown) | |||
Line 7: | Line 7: | ||
| ImageFile2 = Thyronamine3d.png |
| ImageFile2 = Thyronamine3d.png |
||
| ImageSize2 = 200px |
| ImageSize2 = 200px |
||
| |
| PIN = 4-[4-(2-Aminoethyl)phenoxy]phenol |
||
| OtherNames = |
| OtherNames = |
||
|Section1={{Chembox Identifiers |
|Section1={{Chembox Identifiers |
||
Line 46: | Line 46: | ||
* Thyronamine (T0AM) |
* Thyronamine (T0AM) |
||
* [[3-Iodothyronamine]] (T1AM), which is the most notable one as it is a [[trace amine]] found in the [[nervous system]]. It is a possible candidate for the natural ligand of the [[trace amine-associated receptor]] TAAR1 (TAR1), an |
* [[3-Iodothyronamine]] (T1AM), which is the most notable one as it is a [[trace amine]] found in the [[nervous system]]. It is a possible candidate for the natural ligand of the [[trace amine-associated receptor]] TAAR1 (TAR1), an intracellular [[G protein-coupled receptor]]<ref>{{cite journal | vauthors = Piehl S, Hoefig CS, Scanlan TS, Köhrle J | year = 2011 | title = Thyronamines - Past, Present, and Future | journal = Endocrine Reviews | volume = 32 | pages = 64–80 | doi = 10.1210/er.2009-0040 | pmid = 20880963 | issue = 1| doi-access = free }}</ref> |
||
* 3,5-Diiodothyronamine (T2AM) |
* 3,5-Diiodothyronamine (T2AM) |
||
* [[3,5,3'-Triiodothyronamine]] (T3AM) |
* [[3,5,3'-Triiodothyronamine]] (T3AM) |
||
Line 63: | Line 63: | ||
[[Category:Biogenic amines]] |
[[Category:Biogenic amines]] |
||
[[Category:Phenethylamines]] |
[[Category:Phenethylamines]] |
||
[[Category: |
[[Category:4-Hydroxyphenyl compounds]] |
||
[[Category:Thyroid]] |
[[Category:Thyroid]] |
||
[[Category:TAAR1 agonists]] |
[[Category:TAAR1 agonists]] |
Latest revision as of 18:26, 21 October 2024
Names | |
---|---|
Preferred IUPAC name
4-[4-(2-Aminoethyl)phenoxy]phenol | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
MeSH | thyronamine |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C14H15NO2 | |
Molar mass | 229.279 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Thyronamine refers both to a molecule, and to derivatives of that molecule: a family of decarboxylated and deiodinated metabolites of the thyroid hormones thyroxine (T4) and 3,5,3'-triiodothyronine (T3).
Types
[edit]The group includes:
- Thyronamine (T0AM)
- 3-Iodothyronamine (T1AM), which is the most notable one as it is a trace amine found in the nervous system. It is a possible candidate for the natural ligand of the trace amine-associated receptor TAAR1 (TAR1), an intracellular G protein-coupled receptor[1]
- 3,5-Diiodothyronamine (T2AM)
- 3,5,3'-Triiodothyronamine (T3AM)
See also
[edit]References
[edit]- ^ Piehl S, Hoefig CS, Scanlan TS, Köhrle J (2011). "Thyronamines - Past, Present, and Future". Endocrine Reviews. 32 (1): 64–80. doi:10.1210/er.2009-0040. PMID 20880963.